Biotech7 hours ago
Daiichi Sankyo Showcases Expanding DXd ADC Portfolio in Lung Cancer at WCLC25
Daiichi Sankyo presented new results on its DXd antibody-drug conjugates at WCLC25 in Barcelona, showcasing advances in small cell and non-small cell lung cancer. Highlights included...